These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 38655259)
1. Effects of statins beyond lipid-lowering agents in ART-treated HIV infection. Mehraj V; Chen J; Routy JP Front Immunol; 2024; 15():1339338. PubMed ID: 38655259 [TBL] [Abstract][Full Text] [Related]
2. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection. Gebhardt A; Fichtenbaum CJ Expert Opin Pharmacother; 2019 Oct; 20(14):1719-1729. PubMed ID: 31232617 [No Abstract] [Full Text] [Related]
3. The role of statins in the setting of HIV infection. Eckard AR; McComsey GA Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687 [TBL] [Abstract][Full Text] [Related]
4. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons. Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678 [TBL] [Abstract][Full Text] [Related]
5. Clinical management considerations for dyslipidemia in HIV-infected individuals. Kirchner JT Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112 [TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Grinspoon SK; Fitch KV; Overton ET; Fichtenbaum CJ; Zanni MV; Aberg JA; Malvestutto C; Lu MT; Currier JS; Sponseller CA; Waclawiw M; Alston-Smith B; Cooper-Arnold K; Klingman KL; Desvigne-Nickens P; Hoffmann U; Ribaudo HJ; Douglas PS; Am Heart J; 2019 Jun; 212():23-35. PubMed ID: 30928825 [TBL] [Abstract][Full Text] [Related]
7. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. Ahmed MH; Al-Atta A; Hamad MA Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622 [TBL] [Abstract][Full Text] [Related]
8. A Clinical Guide to Combination Lipid-Lowering Therapy. Russell C; Sheth S; Jacoby D Curr Atheroscler Rep; 2018 Mar; 20(4):19. PubMed ID: 29516190 [TBL] [Abstract][Full Text] [Related]
9. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update. Zanetti HR; Roever L; Gonçalves A; Resende ES Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787 [TBL] [Abstract][Full Text] [Related]
10. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions. Fitch KV; Fulda ES; Grinspoon SK Curr Opin HIV AIDS; 2022 Sep; 17(5):293-300. PubMed ID: 35938463 [TBL] [Abstract][Full Text] [Related]
11. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study. Boccara F; Kumar PN; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS; J Am Coll Cardiol; 2020 May; 75(20):2570-2584. PubMed ID: 32234462 [TBL] [Abstract][Full Text] [Related]
12. Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders. Bednasz C; Luque AE; Zingman BS; Fischl MA; Gripshover BM; Venuto CS; Gu J; Feng Z; DiFrancesco R; Morse GD; Ma Q Curr Vasc Pharmacol; 2016; 14(3):280-7. PubMed ID: 26733388 [TBL] [Abstract][Full Text] [Related]
13. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction. Tenenbaum A; Fisman EZ Cardiovasc Diabetol; 2012 Oct; 11():125. PubMed ID: 23057687 [TBL] [Abstract][Full Text] [Related]
14. Optimal management of combined dyslipidemia: what have we behind statins monotherapy? Tenenbaum A; Fisman EZ; Motro M; Adler Y Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960 [TBL] [Abstract][Full Text] [Related]
15. New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins. Kim K; Ginsberg HN; Choi SH Diabetes Metab J; 2022 Jul; 46(4):517-532. PubMed ID: 35929170 [TBL] [Abstract][Full Text] [Related]